Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Fenofibric acid Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs, Mechanisms of Action, and Drug Target
5 October 2023
This article summarized the latest R&D progress of Fenofibric acid, the Mechanism of Action for Fenofibric acid, and the drug target R&D trends for Fenofibric acid.
Latest Hotspot
3 min read
Smart Immune begins administering its ProTcell Therapy SMART101 to leukemia patients in the ReSET-02 Phase I/II study
5 October 2023
Two patients have been administered the initial dosage of SMART101, an allogeneic cell therapy created from donor mobilized peripheral blood stem cells which have been converted into T-cell progenitors utilizing the ProTcell treatment platform by Smart Immune.
Drug Insights
4 min read
Unleashing the Power of Eletriptan hydrobromide: A Comprehensive Review on R&D Breakthroughs, Action Mechanisms, and Drug Target
5 October 2023
This article summarized the latest R&D progress of Eletriptan hydrobromide, the Mechanism of Action for Eletriptan hydrobromide, and the drug target R&D trends for Eletriptan hydrobromide.
Advanced Tech.
4 min read
miRNA and Disease Regulation
5 October 2023
miRNA is an endogenous tiny non-coding RNA, generally 21-23 nucleotides long, with the function of regulating gene expression at the translational level.
Drug Insights
4 min read
A Comprehensive Review of Efavirenz's R&D Innovations and Drug Target Mechanism
5 October 2023
This article summarized the latest R&D progress of Efavirenz, the Mechanism of Action for Efavirenz, and the drug target R&D trends for Efavirenz.
Latest Hotspot
3 min read
Ionis reports positive early results from Phase 3 trial of Olezarsen for familial chylomicronemia syndrome patients
5 October 2023
Ionis declared encouraging preliminary findings from Phase 3 trial of Olezarsen in patients suffering from familial chylomicronemia syndrome.
Drug Insights
4 min read
Pharmaceutical Insights: Torsemide's R&D Progress and its Mechanism of Action on Drug Target
5 October 2023
This article summarized the latest R&D progress of Torsemide, the Mechanism of Action for Torsemide, and the drug target R&D trends for Torsemide.
Valuable Targets
8 min read
Analysis on the Clinical Research Progress of SHP2 Inhibitors
5 October 2023
The Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2), encoded by the PTPN11 gene, is the only confirmed oncogenic protein.
Drug Insights
4 min read
Exploring Diflunisal's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
5 October 2023
This article summarized the latest R&D progress of Diflunisal, the Mechanism of Action for Diflunisal, and the drug target R&D trends for Diflunisal.
Latest Hotspot
3 min read
YS Biopharma Initiates Patient Registration for Key Phase 3 Study on PIKA Rabies Vaccine
5 October 2023
YS Biopharma Co., Ltd., pledged to discovery, develop, produce, and supply innovative vaccines and therapeutic biologics for infectious illnesses and cancer.
Drug Insights
4 min read
Decoding Dextromethorphan polistirex: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
5 October 2023
This article summarized the latest R&D progress of Dextromethorphan polistirex, the Mechanism of Action for Dextromethorphan polistirex, and the drug target R&D trends for Dextromethorphan polistirex.
Valuable Targets
7 min read
Tumor Killers: STAT3 inhibitors
5 October 2023
As a functionally diversified transcription factor, STAT3 can interact with a large number of signal molecules and forms various intra- and extracellular signal pathways.